UB500
ProductThymopentin Injection
Strength(1)1 mg,10 mg (Thymopentin for injection);(2)1 ml:1 mg,1 ml:10 mg(Thymopentin injection);(3)1 ml:1mg,1 ml:10 mg(Thymopentin prefilled injection)
IndicationsNeoplasm; Hepatitis acute; Hepatitis chronic; T-cell immunodeficiency; Autoimmune disorder; Cell-mediated immunodeficiency
TherapeuticsImmunology & Inflammation
GMPPIC/S
RegistrationChina
ModalitiesPeptide
Exclusive Summary
- - Fully off-patent globally, enabling rapid multi-country entry as a mature generic.
- - Targets large immunomodulation needs in older adults (≈771M aged 65+) and chronic HBV (≈254M) with a low-cost injectable option.
- - PIC/S GMP plus prefilled syringe (1 mg/10 mg) enhances compliance and ease-of-use for hospital tenders and distribution.
- - Synthetic pentapeptide manufacturing delivers substantial cost advantage versus biologic immunomodulators.
- - Limited competition outside China creates a differentiation and early-entry window in CIS/MENA/LATAM markets.
Asset Materials
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →